NCT00865033View on ClinicalTrials.gov

A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Type 2 Diabetes

Interventions

DRUG

Metformin HCL Tablets, 1000 mg Sandoz

DRUG

Glucophage 1000 mg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY